Thursday, August 22, 2019 12:45:34 PM
From the PR:
"SWH Reports 6,400% Sequential Quarterly Revenue Growth"
and:
"New Q2 data, taken relative to sales from Home Healthcare operations in its prior quarter, represent a robust sequential quarterly growth rate of 39%."
The rounded raw numbers from the financials:
Q1 showed $2K in Revenue ($100K in Home HC sales weren't reported).
Q2 showed $141K in Revenue including $139K in Home HC sales.
Now watch carefully:
The 6400% comes from (141-2)/2...which is an increase of 6450%. Note that it comes about because NO Home HC sales were reported in Q1 even thought they had $100K in sales from that sector.*** So that's definitely nuts...and extra nuts for being in a Headline.
Moving on to the source of Home Healthcare's "robust sequential quarterly growth rate of 39%":
Again, watch carefully:
As noted "During the three months ended March 31, 2019, the Company recognized income and costs in the amounts of $100,347 and $113,045, respectively, pursuant to the PHH agreement.
The Income Statement shows HHC Revenues of $139K For the Six Months Ended June 30, 2019.
Obviously then there were HHC Revenues of $39K in the second quarter....
A DECREASE OF $61K from the $100K recognized in the first quarter.
Only in LaLaLAND does that "represent a robust sequential quarterly growth rate of 39%". It's BACK ASSWARDS!!!
These guys think we're all stupid and it's really only some of us.
***From the current Report: "During the three months
ended March 31, 2019, the Company recognized income and costs in the amounts of $100,347 and $113,045,
respectively, pursuant to the PHH agreement."
https://backend.otcmarkets.com/otcapi/company/financial-report/221344/content
https://backend.otcmarkets.com/otcapi/company/financial-report/228639/content
But can it core A apple?
Yes Ralph, of course it can core A apple.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM